Britain's Terry Smith made public for the first time on Thursday why his fund dumped its Diageo stake last year, citing ...

Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...

AquaSculpt is a breakthrough weight reduction product that claims to change the way people think about losing weight.

We’ve all been there — feeling super inspired about a new weight loss meal plan or workout routine. You’re crushing it day ...

Donald Trump joked in his last call with Sir Keir Starmer about coyotes needing weight-loss drugs after becoming fat feasting ...

LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...

"Coverage for these weight-loss drugs has significant cost implications for employers, as a previous KFF analysis estimated ...

Maridebart cafraglutide, a novel injectable GIP receptor antagonist/GLP-1 receptor agonist, reduced body weight by ...

Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...

British fund manager Terry Smith has sold his stake in Diageo Plc, citing concerns about the management of the drinks company ...